Literature DB >> 5838405

Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.

A O Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5838405      PMCID: PMC2094615     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


× No keyword cloud information.
  16 in total

1.  Metabolic studies in Wilson's disease using Cu64.

Authors:  A G BEARN; H G KUNKEL
Journal:  J Lab Clin Med       Date:  1955-04

2.  Treatment of Wilson's disease with penicillamine.

Authors:  J M WALSHE
Journal:  Lancet       Date:  1960-01-23       Impact factor: 79.321

3.  Effect of estrogens on copper metabolism in Wilson's disease.

Authors:  J L GERMAN; A G BEARN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

4.  Observations on ceruloplasmin and methods for its estimation.

Authors:  S O'REILLY
Journal:  Neurology       Date:  1961-03       Impact factor: 9.910

5.  Fatty cirrhosis in the rat. I. A method of grading specimens.

Authors:  F W HOFFBAUER
Journal:  AMA Arch Pathol       Date:  1959-08

6.  Wilson's disease; report of a case with normal serum ceruloplasmin level.

Authors:  E ENGER
Journal:  Acta Med Scand       Date:  1959-02-25

7.  Studies on copper metabolism. XXIV. Hypocupremia in infancy.

Authors:  A ZIPURSKY; H DEMPSEY; H MARKOWITZ; G CARTWRIGHT; M M WINTROBE
Journal:  AMA J Dis Child       Date:  1958-08

8.  Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson's disease.

Authors:  S OKINAKA; M YOSHIKAWA; M TOYODA; T MOZAI; Y TOYOKURA; M KAMEYAMA
Journal:  AMA Arch Neurol Psychiatry       Date:  1954-11

9.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

10.  THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.

Authors:  I Sternlieb; A G Morell; W D Tucker; M W Greene; I H Scheinberg
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.